Monday , March 1 2021

High sensitivity with break cancers detection for 1-view digital breast tomos syndis



This article first appeared in clinical advisor.

A digital breast tomosynitisis invented by the breast cancer discovered by the compression bomb detecting reduced sensitivity and low specification than a view of digital mammography.
A digital breast tomosynitisis invented by the breast cancer discovered by the compression bomb detecting reduced sensitivity and low specification than a view of digital mammography.

Using 1-view digital breast tomomosciasis with a reduced compression strength in breast cancer screenings can result in a relatively high sensitivity and smell identification with 2-look digital mammography. This may reduce radiation dose and screening liabilities. Published Lancet Oncology.

A set of investigators of the Malmo Breast Tomosentes Screening Trail (MBTST, ClinicalTrials.gov identifier: NCT01091545) made a perspective. Compared to the accuracy of 1-digit digital breast tomoscondis, a population diagnostic diagnostic study conducted 2-way digital mammography and cancer detection

The women between 40 and 74 have been asked to take part in a National Brake Cancer Screen in Malmö, Sweden. Qualified women of study (n = 14,848) were shown in 2-look digital breast mammography, and a 1-view digital Breast Tomoscience 1 breast cancer screening visit was reduced.

Detective sensitivity and specification are measured by basic measurements; Cancer detection, recurrence, cancers at intervals, favorable predictable value for screen removal, and negative results for both types of negative predictive values.

Digital breast Tomoscondes have high sensitivity (81% vs 60.4%), while comparing with digital mammography, but it is clear (97.2% vs 98.1%). 8.7 Cancer patients with 6.5 cancers in 1000 women were diagnosed with cancer. Cancer detection of a digital breast implants of 2-way digital mammography is very high.

Compared to digital mammography (3.6% vs 2.5%), women in a large percentage were recalled in cancerous lesions found by tymosentiasis. Digital Tomoscondes and Digital Mammography are respectively 24.1% and 25.9% respectively. Negative predictions for digital tomosconds and digital mammography are 99.8% and 99.6% respectively. Over 1000 women were shown at 1.48 intervals after trial screening.

"At last we showed the breast cancer screening [1]Digital Breast Tomoscience, a minimal compression force, has more sensitivity, a bit less to detect breast cancer [2]Digital mammography, and a low dose of radiation, and can also reduce screen-reading weight [2]See also with digital breast tommosanthis [2]Digital mammography, "wrote the researchers." If there is support of cost-effectiveness studies, [1]The future breast cancer screening method is considered to be digital breast tomoscentissin warrants. "

Reference

  1. Zarricin S., Lang K, Reszo A, et al; For MBTST study. Malmo breast Tomosynitis Screening Trail (MBTST): A two-view mammography, prospective, population-based, diagnostic accuracy in one-sighted breast tomomosciase and malmo breast tomosynthesis screening trial (MBTST) [published online October 12, 2018]. Lancet on call. doi: 10.1016 / S1470-2045 (18) 30521-7


Source link